SCHEMBL20414730

SCHEMBL20414730

CCOc1cc(C)cc(O)c1O

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 3/20 0.55
▸ KDM4E B2RXH2 3/20 0.55
▸ MAPT P10636 3/20 0.55
▸ KMT2A Q03164 2/20 0.55
▸ POLB P06746 1/20 0.55
▸ GAA P10253 1/20 0.55
▸ APEX1 P27695 1/20 0.55
▸ MPI P34949 1/20 0.55
▸ RECQL P46063 1/20 0.55
▸ SELL P14151 1/20 0.54
▸ SELP P16109 1/20 0.54
▸ SELE P16581 1/20 0.54
▸ ACHE P22303 1/20 0.42
▸ PTPN1 P18031 1/20 0.42
▸ MEN1 O00255 1/20 0.41
▸ ESR1 P03372 1/20 0.40
▸ HPGD P15428 1/20 0.40
▸ ALOX15 P16050 1/20 0.40
▸ BACE1 P56817 1/20 0.40
▸ HSD17B10 Q99714 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10972323 0.91 ALDH1A1 (0.43) ALDH1A1KDM4EMAPTKMT2APOLB
SCHEMBL29200157 0.85 KDM4E (0.49) ALDH1A1KDM4EMAPTKMT2APOLB
SCHEMBL8990168 0.85 KDM4E (0.39) ALDH1A1KDM4EMAPTKMT2APOLB
SCHEMBL29200150 0.83 ERN1 (0.50) KDM4EMAPTKMT2APOLBGAA
SCHEMBL19732199 0.82 KMT2A (0.49) ALDH1A1KDM4EMAPTKMT2APOLB
SCHEMBL19732197 0.82 BACE1 (0.44) ALDH1A1KDM4EMAPTKMT2APOLB
SCHEMBL20763098 0.82 ALDH1A1 (0.42) ALDH1A1KDM4EMAPTKMT2APOLB
SCHEMBL19732196 0.82 HSD17B10 (0.48) ALDH1A1KDM4EMAPTKMT2APOLB
SCHEMBL23804828 0.78 KDM4E (0.48) ALDH1A1KDM4EMAPTKMT2APOLB
SCHEMBL27852653 0.77 ALDH1A1 (0.48) ALDH1A1KDM4EMAPTKMT2APOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3571180-B1 PRODUCTION OF HIGHLY PURE META,META-COUPLED BIS(4-ALKYLPHENOL) DERIVATIVES AND USES THEREOF UNIV LEUVEN KATH (BE) 2024-12-18 — — EP disclosed
US-20210070684-A1 PRODUCTION OF HIGHLY PURE META,META-COUPLED BIS(4-ALKYLPHENOL) DERIVATIVES AND USES THEREOF KATHOLIEKE UNIVERSITEIT LEUVEN (BE) 2021-03-11 — — US disclosed
EP-3571180-A1 PRODUCTION OF HIGHLY PURE META,META-COUPLED BIS(4-ALKYLPHENOL) DERIVATIVES AND USES THEREOF Katholieke Universiteit Leuven (BE) 2019-11-27 — — EP disclosed
WO-2018134427-A1 PRODUCTION OF HIGHLY PURE META,META-COUPLED BIS(4-ALKYLPHENOL) DERIVATIVES AND USES THEREOF KATHOLIEKE UNIVERSITEIT LEUVEN (BE) 2018-07-26 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210070684-A1 PRODUCTION OF HIGHLY PURE META,META-COUPLED BIS(4-ALKYLPHENOL) DERIVATIVES AND USES THEREOF MMS19, PCBP1, PBRM1 ALDH1A1 1877/4885KDM4E 2316/4885MAPT 8/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback